In the search for therapeutic combinations for the treatment of cancer, the pairing of targeted inhibitors of oncogenic driver pathways with immunotherapy has largely been overlooked. In Nature, Canon et al. (2019) describe how the novel KRAS-G12C inhibitor AMG 510 can potentiate immune rejection in combination with immune checkpoint blockade.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.immuni.2019.12.013 | DOI Listing |
Publication Analysis
Top Keywords
mutant kras
4
kras heart
4
heart tumor
4
tumor immune
4
immune evasion
4
evasion search
4
search therapeutic
4
therapeutic combinations
4
combinations treatment
4
treatment cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!